Endocrine pancreatic insufficiency in chronic pancreatitis

Pancreatology

Volumn 5, Issue 2-3, 2005, Pages 122-131

  Angelopoulos, Nicholas ^a   Dervenis, Christos ^b   Goula, Anastasia ^c   Rombopoulos, Grigorio ^a   Livadas, Sarantis ^a   Kaltsas, Dimitrios ^a   Kaltzidou, Victoria ^a   Tolis, George ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b AGIA OLGA HOSPITAL   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Chronic pancreatitis; Elective pancreatic surgery; Endocrine pancreas; Glucagon; Insulin; Pancreatic diabetes

Indexed keywords

BENTIROMIDE; C PEPTIDE; GHRELIN; GLUCOSE; INSULIN; NEUROPEPTIDE Y; PEPTIDE YY; PREDNISOLONE; SELENIUM; SOMATOSTATIN; ZINC;

ACCURACY; CELL INFILTRATION; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENDOCRINE FUNCTION; EXOCRINE SECRETION; FATTY ACID OXIDATION; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HEALTH STATUS; HORMONE DEFICIENCY; HYPOTHESIS; IMMIGRANT; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; INSULIN SENSITIVITY; LIFESTYLE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CALCIFICATION; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; PANCREAS ISLET; PANCREAS RESECTION; PANCREAS SURGERY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEIN DEGRADATION; REVIEW; RISK ASSESSMENT; SELENIUM DEFICIENCY; SIGNAL TRANSDUCTION; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; T LYMPHOCYTE; VALIDATION PROCESS; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

EID: 19944398776     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000085264     Document Type: Review

References (101)

1. Brunicardi FC, Dyen Y, Brostrom L, Kleinman R, Colonna J, Gelabert H, Gingerich R: The circulating hormonal milieu of the endocrine pancreas in healthy individuals, organ donors, and the isolated perfused human pancreas. Pancreas 2000;21:203-211.
2. Robben JH, Van Garderen E, Mol JA, Wolfswinkel J, Rijnberk A: Locally produced growth hormone in canine insulinomas. Mol Cell Endocrinol 2002;197:187-195.
3. Adeghate E, Ponery AS: Large reduction in the number of galanin-immunoreactive cells in pancreatic islets of diabetic rats. J Neuroendocrinol 2001;13:706-710.
4. Basmaciogullari A, Cras-Meneur C, Czernichow P, Scharfmann R: Pancreatic pattern of expression of thyrotropin-releasing hormone during rat embryonic development. J Endocrinol 2000;166:481-488.
5. Broglio F, Gottero C, Arvat E, Ghigo E: Endocrine and non-endocrine actions of Ghrelin. Horm Res 2003;59:109-117.
6. 2+ influx in rat pancreatic beta-cells. Diabetes 1999;48:1741-1746.
7. Cavallini G, Benini L, Brocco G, Riela A, Bovo P, Pederzoli P, Angelini G, Pelle C, Bertelli G, Scuro LA: The fecal chymotrypsin photometric assay in the evaluation of exocrine pancreatic capacity. Comparison with other direct and indirect pancreatic function tests. Pancreas 1989;4:300-304.
8. Banks PA: Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc 2002;56:S226-S230.
9. Ammann RW, Akovbiantz A, Largiader F, Schueler G: Course and outcome of chronic pancreatitis. Gastroenterology 1984;86:820-828.
10. International Pancreatitis Study Group: Prognosis of chronic pancreatitis: An international multicenter study. Am J Gastroenterol 1994;89:1467-1471.
11. Copenhagen Pancreatitis Study: An interim report from a prospective multicentre study. Scand J Gastroenterol 1981;16:305-312.
12. Ammann RW, Heitz PU, Kloppel G: Course of alcoholic chronic pancreatitis: A prospective clinicomorphological long-term study. Gastroenterology 1996;111:224-231.
13. Olsen TS: The incidence and clinical relevance of chronic inflammation in the pancreas in autopsy material. Acta Pathol Microbiol Scand A 1978;86:361-365.
14. Rothenbacher D, Low M, Hardt P, Klor H, Ziegler H, Brenner H: Prevalence and determinants of exocrine pancreatic insufficiency among older adults: Results of a population based study. Pancreatology 2004;4:193.
15. Lankisch PG, Lohr-Happe A, Otto J, Creutzfeldt W: Natural course in chronic pancreatitis. Digestion 1993;54:148-155.
16. Layer P, DiMagno EP: Early and late onset in idiopathic and alcoholic chronic pancreatitis. Different clinical courses. Surg Clin North Am 1999;79:847-860.
17. Forsmark C: Chronic Pancreatitis; in Feldman (ed): Sleisenger & Fordtran's Gastrointestinal and Liver Disease, ed 7. Elsevier, 2002, pp 945-948.
18. Balaji LN, Tandon RK, Tandon BN, Banks PA: Prevalence and clinical features of chronic pancreatitis in southern India. Int J Pancreatol 1994;15:29-34.
19. DiMagno EP, Layer P, Clain JE: Chronic pancreatitis; in Go VLW, Gardner JD, Brooks FP (eds): The Exocrine Pancreas: Biology, Pathobiology and Diseases. New York, Raven Press, 1986, pp 541-575.
20. Larsen S, Hilsted J, Tronier B, Worning H: Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. Metabolism 1987;36:964-967.
21. Hanck C, Schneider A, Whitcomb DC: Genetic polymorphisms in alcoholic pancreatitis. Best Pract Res Clin Gastroenterol 2003;17:613-623.
22. Gorry M, Gabbaizadeh D, Furey W, Gates LK Jr, Preston RA, Aston CE, Zhang Y, Ulrich C, Ehrlich GD, Whitcomb DC: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997;113:1063-1068.
23. Gaia E, Salacone P, Gallo M, Promis GG, Brusco A, Bancone C, Carlo A: Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci 2002;47:2416-2421.
24. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor. Kazal type 1 are associated with chronic pancreatitis, Nat Gen 2000;25:213-216.
25. Pareja E, Artigues E, Aparisi L, Fabra R, Martinez V, Trullenque R: Exocrine pancreatic changes following acute attack of biliary pancreatitis. Pancreatology 2002;2:478-483.
26. Angelini G, Caballini G, Pederzoli P: Long-term outcome of acute pancreatitis: A prospective study with 118 patients. Digestion 1993;54:143-147.
27. Ibars EP, Sanchez de Rojas EA, Quereda LA, Ramis RF, Sanjuan VM, Peris RT: Pancreatic function after acute biliary pancreatitis: Does it change? World J Surg 2002;26:479-486.
28. Stastna R, Karasova L, Svacek J, Petrasek R, Winkler L, Lanska V, Skala I, Maly J: Endocrine pancreatic secretion in patients after acute pancreatitis. Pancreas 1990;5:358-360.
29. Boreham B, Ammori BJ: A prospective evaluation of pancreatic exocrine function in patients with acute pancreatitis: Correlation with extent of necrosis and pancreatic endocrine insufficiency. Pancreatology 2003;3:303-308.
30. Kloppel G: Progression from acute to chronic pancreatitis. A pathologist's view. Surg Clin North Am 1999;79:801-814.
31. Ammann RW, Muellhaupt B: The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999;116:1132-1140.
32. Bank S, Marks IN, Vinik AI: Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol 1975;64:13-22.
33. Cavallini G, Vaona B, Bovo P, Cigolini M, Rigo L, Rossi F, Tasini E, Brunori MP, Di Francesco V, Frulloni L: Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance. Dig Dis Sci 1993;38:497-501.
34. Vessby B: Dietary fat and insulin action in humans. Br J Nutr 2000;83(suppl 1):S91-S96.
35. Quilliot D, Walters E, Bohme P, Lacroix B, Bonte JP, Fruchart JC, Drouin P, Duriez P, Ziegler O: Fatty acid abnormalities in chronic pancreatitis: Effect of concomitant diabetes mellitus. Eur J Clin Nutr 2003;57:496-503.
36. Larsen S, Hilsted J, Philipsen EK, Tronier B, Christensen NJ, Damkjaer Nielsen M, Worning H: Glucose counter regulation in diabetes secondary to chronic pancreatitis. Metabolism 1990;39:138-143.
37. Keller U, Szollosy E, Varga L, Gyr K: Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis. Dig Dis Sci 1984;29:853-857.
38. Nakamura T, Imamura K, Takebe K, Terada A, Arai Y, Tandoh Y, Yamada N, Ishii M, Machida K, Suda T: Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis. Int J Pancreatol 1996;20:169-175.
39. Kannan V, Nabarro JD, Cotton PB: Glucagon secretion in chronic pancreatitis. Horm Res 1979;11:203-212.
40. Hamberg O, Andersen V, Sonne J, Larsen S, Vilstrup H: Urea synthesis in patients with chronic pancreatitis: Relation to glucagon secretion and dietary protein intake. Clin Nutr 2001;20:493-501.
41. Larsen S: Diabetes mellitus secondary to chronic pancreatitis. Dan Med Bull 1993;40:153-162.
42. Owyang C: Endocrine changes in pancreatic insufficiency; in Go VLW, DiMagno EP (eds): The Pancreas: Biology, Pathobiology and Diseases. New York, Raven Press, 1993, pp 803-813.
43. Alberti KGMM: Diabetes Secondary to Pancreatopathy: An example of brittle diabetes; in Tiengo A, Alberti KGMM, Del Prato S, Vranic M (eds): Diabetes Secondary to Pancreatopathy. Amsterdam. Excerpta Medica, 1988, pp 7-20.
44. Okuno G, Oki A, Kawakami F, Doi K, Baba S: Prevalence and clinical features of diabetes mellitus secondary to chronic pancreatitis in Japan: A study by questionnaire. Diabetes Res Clin Pract 1990;10:65-71.
45. Hardt PD, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Klor HU: Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology 2002;2:30-33.
46. Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Jaeger C, Teichmann J, Bretzel RG, Hollenhorst M, Kloer HU: High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pancreatology 2003;3:395-402.
47. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Levy P: Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000;119:1324-1332.
48. Bhatia E, Baijal SS, Kumar KR, Choudhuri G: Exocrine pancreatic and beta-cell function in malnutrition-related diabetes among North Indians. Diabetes Care 1995;18:1174-1178.
49. Del Prato S, Riva F, Devide A, Nosadini R, Fedele D, Tiengo A: Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis. Acta Diabetol Lat 1980;17:111-118.
50. Linde J, Nilsson LH, Barany FR: Diabetes and hypoglycemia in chronic pancreatitis. Scand J Gastroenterol 1977;12:369-373.
51. Sjoberg RJ, Kidd GS: Pancreatic diabetes mellitus. Diabetes Care 1989;12:715-724.
52. Mergener K, Baillie J: Chronic pancreatitis. Lancet 1997;350:1379-1385.
53. Verdonk CA, Palumbo PJ, Gharib H, Bartholomew LG: Diabetic microangiopathy in patients with pancreatic diabetes mellitus. Diabetologia 1975;11:395-400.
54. Maekawa N, Ohneda A, Kai Y, Saito Y, Koseki S: Secondary diabetic retinopathy in chronic pancreatitis. Am J Ophthalmol 1978;85: 835-840.
55. Gullo L, Parenti M, Monti L, Pezzilli R, Barbara L: Diabetic retinopathy in chronic pancreatitis. Gastroenterology 1990;98:1577-1581.
56. Ziegler O, Candiloros H, Guerci B, Got I, Crea T, Drouin P: Lower-extremity arterial disease in diabetes mellitus due to chronic pancreatitis. Diabete Metab 1994;20:540-545.
57. Mohan V, Premalatha G, Padma A, Chari ST, Pitchumoni CS: Fibrocalculous pancreatic diabetes. Long-term survival analysis. Diabetes Care 1996;19:1274-1278.
58. Barman KK, Premalatha G, Mohan V: Tropical chronic pancreatitis. Postgrad Med J 2003;79:606-615.
59. Mohan V, Premalatha G, Pitchumoni CS: Tropical chronic pancreatitis: An update. J Clin Gastroenterol 2003;36:337-346.
60. Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Murase T, Hashimoto M, Watanabe G, Matsushita H, Endo Y, Yoshizaki H, Kosuge T, Sakamoto M, Takeuchi K: Evidence of primary beta-cell destruction by T-cells and beta-cell differentiation from pancreatic ductal cells in diabetes associated with active autoimmune chronic pancreatitis. Diabetes Care 2001;24:1661-1667.
61. Okazaki K, Chiba T: Autoimmune related pancreatitis. Gut 2002;51:1-4.
62. Okazaki K, Tamura S, Morita M, Nishimori I, Yamamoto Y, Yamamoto Y: Interspecies crossreactive antigen of the pancreatic duct cell prepared by monoclonal antibody. A preliminary study of its immunological significance in patients with chronic pancreatitis associated with Sjogren's syndrome. Int J Pancreatol 1989;5:359-377.
63. Versapuech JM, Labayle D, Grange D, Fischer D, Kemeny F, D'Hubert E: Sclerosing cholangitis, chronic pancreatitis and Sjogren's syndrome. Ann Med Interne 1986;137:147-151.
64. Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Odawara M, Murase T, Hashimoto M, Watanabe G, Matsushita H, Inoko H, Takeuchi K: Corticosteroid- responsive diabetes mellitus associated with autoimmune pancreatitis: Pathological examinations of the endocrine and exocrine pancreas. Ann NY Acad Sci 2002;958:152-159.
65. Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Murase T, Hashimoto M, Takeuchi K: Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 2000;356:910-911.
66. Horiuchi A, Kaneko T, Yamamura N, Nagata A, Nakamura T, Akamatsu T, Mukawa K, Kawa S, Kiyosawa K: Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am J Gastroenterol 1996;91:2607-2609.
67. Tabata M, Kitayama J, Kanemoto H, Fukasawa T, Goto H, Taniwaka K: Autoimmune pancreatitis presenting as a mass in the head of the pancreas: A diagnosis to differentiate from cancer. Am Surg 2003;69:363-366.
68. Habener JF: The incretin concept and its relevance to diabetes. Endocrinol Metab Clin North Am 1993;22:775-794.
69. Kieffer TJ, McIntosh CH, Pederson RA: Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 1995;136:3585-3596.
70. Brown JC, Otte S: Clinical studies with gastric inhibitory polypeptide. World J Surg 1979;3:553-558.
71. Vinik AI, Kalk WJ, Botha JL, Jackson WP, Blake KC: The inexhaustible beta cell. Diabetes 1976;25:11-15.
72. Neary NM, Goldstone AP, Bloom SR: Appetite regulation: From the gut to the hypothalamus. Clin Endocrinol 2004;60:153-160.
73. Wehler M, Nichterlein R, Fischer B, Farnbacher M, Reulbach U, Hahn EG, Schneider T: Factors associated with health-related quality of life in chronic pancreatitis. Am J Gastroenterol 2004;99:138-146.
74. Czako L, Takacs T, Hegyi P, Pronai L, Tulassay Z, Lakner L, Dobronte Z, Boda K, Lonovics J: Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003;17:597-603.
75. Boden G: Diabetes Secondary to Pancreatopathy: Amino acid metabolism in diabetes secondary to pancreatopathy; in Tiengo A, Alberti KGMM, Del Prato S, Vranic M (eds): Diabetes Secondary to Pancreatopathy. Amsterdam, Excerpta Medica, 1988, pp 179-186.
76. Quilliot D, Dousset B, Guerci B, Dubois F, Drouin P, Ziegler O: Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitis. Pancreas 2001;22:299-306.
77. Glauert HP, Beaty MM, Clark TD, Greenwell WS, Chow CK: Effect of dietary selenium on the induction of altered hepatic foci and hepatic tumors by the peroxisome proliferator ciprofibrate. Nutr Cancer 1990;14:261-271.
78. Cabre E, Periago JL, Mingorance MD, Fernandez-Banares F, Abad A, Esteve M, Gil A, Lachica M, Gonzalez-Huix F, Gassull MA: Factors related to the plasma fatty acid profile in healthy subjects, with special reference to antioxidant micronutrient status: A multivariate analysis. Am J Clin Nutr 1992;55:831-837.
79. Oliver MF: Diet and coronary heart disease. Hum Nutr Clin Nutr 1982;36:413-427.
80. Gullo L, Stella A, Labriola E, Costa PL, Descovich G, Labo G: Cardiovascular lesions in chronic pancreatitis: A prospective study. Dig Dis Sci 1982;27:716-722.
81. Maartense S, Ledeboer M, Masclee AA: Chronic pancreatitis: Relation between function and morphology. Dig Liver Dis 2004;36:61-67.
82. Kobayashi T, Nakanishi K, Kajio H, Morinaga S, Sugimoto T, Murase T, Kosaka K: Pancreatic cytokeratin: An antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:363-370.
83. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y: A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000;342: 301-307.
84. Nyboe Andersen B, Krarup T, Thorsgaard Pedersen NT, Faber OK, Hagen C, Worning H: B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function. Diabetologia 1982;23:86-89.
85. Kalk WJ, Vinik AI, Jackson WP, Bank S: Insulin secretion and pancreatic exocrine function in patients with chronic pancreatitis. Diabetologia 1979;16:355-358.
86. Ebert R, Creutzfeldt W, Brown JC, Frerichs H, Arnold R: Response of gastric inhibitory polypeptide (GIP) to test meal in chronic pancreatitis - Relationship to endocrine and exocrine insufficiency. Diabetologia 1976;12:609-612.
87. Lankisch PG, Lembcke B, Wemken G, Creutzfeldt W: Functional reserve capacity of the exocrine pancreas. Digestion 1986;35:175-181.
88. Von Tirpitz C, Glasbrenner B, Mayer D, Malfertheiner P, Adler G: Comparison of different endocrine stimulation tests in nondiabetic patients with chronic pancreatitis. Hepatogastroenterology 1998;45:1111-1116.
89. Domschke S, Stock KP, Pichl J, Schneider MU, Domschke W: Beta-cell reverse capacity in chronic pancreatitis. Hepatogastroenterology 1985;32:27-30.
90. Yamamura T, Mori K, Tatsumi M, Kotoura Y, Yoshiya K, Itoh N, Seino Y: Availability of plasma pancreatic polypeptide measurement in diagnosis of chronic pancreatitis. Scand J Gastroent 1981;16:757-761.
91. Farkas G, Leindler L, Daroczi M, Farkas G Jr: Organ-preserving pancreatic head resection in chronic pancreatitis. Br J Surg 2003;90:29-32.
92. Ammann RW, Akovbiantz A, Largiader F, Schueler G: Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology 1984;86:820-828.
93. Sielezneff I, Malouf A, Salle E, Brunet C, Thirion X, Sastre B: Long term results of lateral pancreaticojejunostomy for chronic alcoholic pancreatitis. Eur J Surg 2000;166:58-64.
94. Eddes EH, Masclee AM, Gooszen HG, Frolich M, Lamers CB: Effect of duodenum-preserving resection of the head of the pancreas on endocrine and exocrine pancreatic function in patients with chronic pancreatitis. Am J Surg 1997;174:387-392.
95. Bittner R, Butters M, Buchler M, Nagele S, Roscher R, Beger HG: Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy. Pancreas 1994;9:47-53.
96. Maartense S, Ledeboer M, Bemelman WA, Ringers J, Frolich M, Masclee AA: Effect of surgery for chronic pancreatitis on pancreatic function: Pancreatico-jejunostomy and duodenum-preserving resection of the head of the pancreas. Surgery 2004;135:125-130.
97. Jang JY, Kim SW, Park SJ, Park YH: Comparison of the functional outcome after pylorus-preserving pancreatoduodenectomy: Pancreatogastrostomy and pancreatojejunostomy. World J Surg 2002;26:366-371.
98. Knish M, Ryu M, Kinoshita T, Inoue K: Pathophysiology after pylorus-preserving pancreatoduodenectomy: A comparative study of pancreatogastrostomy and pancreatojejunostomy. Hepatogastroenterology 1999;46:1181-1186.
99. Prinz RA, Greenlee HB: Pancreatic duct drainage in 100 patients with chronic pancreatitis. Ann Surg 1981;194:313-320.
100. Frey CF, Mayer KL: Comparison of local resection of the head of the pancreas combined with longitudinal pancreaticojejunostomy (Frey procedure) and duodenum-preserving resection of the pancreatic head (Beger procedure). World J Surg 2003;27:1217-1230.
101. Tran K, Van Eijck C, Di Carlo V, Hop WC, Zerbi A, Balzano G, Jeekel H: Occlusion of the pancreatic duct versus pancreaticojejunostomy: A prospective randomized trial. Ann Surg 2002;236:422-428.